CNS Pharmaceuticals, Inc. (CNSP)


Stock Price Forecast

April 24, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading CNS Pharmaceuticals, Inc. chart...

About the Company

We do not have any company description for CNS Pharmaceuticals, Inc. at the moment.

Sector

Life Sciences

Industry

Pharmaceutical Preparations

Employees

4

Exchange

Nasdaq

$M

Total Revenue

4

Employees

$1M

Market Capitalization

-0.04

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $CNSP News

CNS Pharmaceuticals to Present at the LSX World Congress 2024

2d ago, source:

HOUSTON, TX / ACCESSWIRE / April 23, 2024 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP)("CNS" or the "Company"), a ...

Tinygemsbreaks CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO To Present At LSX World Congress 2024

2d ago, source:

CNS Pharmaceuticals (NASDAQ: CNSP) , a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic canc ...

CNS Pharmaceuticals Reports Full Year 2023 Financial Results and Highlights Recent Corporate and Clinical Achievements

24d ago, source: Nasdaq

About CNS Pharmaceuticals, Inc.CNS Pharmaceuticals is a clinical-stage pharmaceutical company developing a pipeline of anti-cancer drug candidates for the treatment of primary and metastatic ...

Biomednewsbreaks CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Spotlighted In Upcoming Virtual Investor Lunch Break Event

3d ago, source:

CNS Pharmaceuticals (NASDAQ: CNSP) , a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic canc ...

CNS Pharmaceuticals Inc.

29d ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

CNS Pharmaceuticals (NASDAQ: CNSP) CEO to Present at LSX World Congress 2024

2d ago, source:

Detailed price information for Cns Pharmaceuticals Inc (CNSP-Q) from The Globe and Mail including charting and trades.

CNS Pharmaceuticals to Present at the LSX World Congress 2024

3d ago, source: Stockhouse

HOUSTON, TX / ACCESSWIRE / April 23, 2024 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for ...

CNS Pharmaceuticals, Inc.: CNS Pharmaceuticals to Present at the LSX World Congress 2024

2d ago, source:

HOUSTON, TX / ACCESSWIRE / April 23, 2024 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...